You are here

  • Home
  • Archive
  • Volume 12, Issue 1
  • Review: anticholinergics but not β2 agonists reduce exacerbations requiring hospital admission and respiratory deaths in COPD

Article Text

Article menu
Download PDFPDF
Therapeutics
Review: anticholinergics but not β2 agonists reduce exacerbations requiring hospital admission and respiratory deaths in COPD

https://doi.org/10.1136/ebm.12.1.13

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • For correspondence: Dr S R Salpeter, Stanford University School of Medicine, Stanford, CA, USA. salpeter{at}stanford.edu

    • Source of funding: no external funding.